SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-012156
Filing Date
2020-08-07
Accepted
2020-08-07 16:08:54
Documents
107
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akrx-20200630.htm   iXBRL 10-Q 3060664
2 EX-31.1 exhibit311-06302020.htm EX-31.1 11536
3 EX-31.2 exhibit312-06302020.htm EX-31.2 11775
4 EX-32.1 exhibit321-06302020.htm EX-32.1 5555
5 EX-32.2 exhibit322-06302020.htm EX-32.2 5527
  Complete submission text file 0001628280-20-012156.txt   15053106

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20200630.xsd EX-101.SCH 87645
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20200630_cal.xml EX-101.CAL 139229
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20200630_def.xml EX-101.DEF 422650
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20200630_lab.xml EX-101.LAB 924106
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20200630_pre.xml EX-101.PRE 685722
11 EXTRACTED XBRL INSTANCE DOCUMENT akrx-20200630_htm.xml XML 3448489
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 201085291
SIC: 2834 Pharmaceutical Preparations